ConclusionFondaparinux Na was a safe and effective treatment for NSTEMI.
结论磺达肝癸钠治疗非st段抬高急性冠脉综合征安全有效。
Conclusions: Excess adiposity is strongly related to first NSTEMI occurring prematurely.
结论：过度肥胖与过早发生初发nstemi显著相关。
Early revascularization was associated with a similar improvement in long-term outcomes for both STEMI and NSTEMI.
早期再血管化在改善STEMI和NSTEMI的长期结果方面结果相似。
The CRUSADE initiative included high-risk patients with unstable angina and non–ST-segment elevation myocardial infarction (NSTEMI).
CRUSADE入选包括高危不稳定性心绞痛和非ST段抬高心梗患者。
Objective: To observe the clinical effect and safety in treatment of non-ST elevation myocardial infarction (NSTEMI) with clopidogrel.
目的：观察氯吡格雷治疗急性非st段抬高心肌梗死(NSTEMI)的临床疗效及安全性。
Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).
急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。
Baseline prediction of bleeding risk can complement ischemic risk prediction for optimization of NSTEMI care; however, existing models are not well suited for this purpose.
出血风险的基线预测因素可完善缺血风险的预测，优化NSTEMI治疗，但现有模型不太适用于此目的。
These data suggest that in clinical investigations of early revascularization among patients with NSTEMI, extended follow-up may be necessary to demonstrate treatment benefit.
这些资料提示在NSTEMI患者的早期再血管化的临床研究中，延长随访时间对于验证治疗获益是必要的。
Objective:To study the characteristics of arrhythmias in patients with acute ST segment elevation myocardial infarction(STEMI) and non-ST segment elevation myocardial infarction(NSTEMI).
目的：对比分析急性ST段抬高性心肌梗死与非ST段抬高性心肌梗死患者并发心律失常的特点。
The monofactor analysis shows:the past history of angina and diabetes mellitus are the predicting risk factors of major cardiovascular event in the 6- month follow-up in NSTEMI patients.
单因素分析显示，冠心病病史和糖尿病是NSTEMI患者6个月发生心血管事件的危险因子。
The monofactor analysis shows:the past history of angina and diabetes mellitus are the predicting risk factors of major cardiovascular event in the 6- month follow-up in NSTEMI patients.
单因素分析显示，冠心病病史和糖尿病是NSTEMI患者6个月发生心血管事件的危险因子。
应用推荐